CASE STUDY
05
Genome sequencing portfolio
SHAPING ILLUMINA’S WORLD-CLASS GENOME SEQUENCING PORTFOLIO
Can one bold design set the gold standard for a decade?
One design unified 12+ platforms—driving adoption and brand loyalty in labs worldwide.
The iScan DNA sequencer set a new gold standard, shaping the genomics industry for the decade to come—streamlining workflows, improving lab interaction, and giving Illumina a bold visual identity. That success led to a decade-long collaboration with the CEO to evolve a distinct design language that scaled across the entire sequencing portfolio, establishing illumina as the global leader in genomic sequencing.
The result: Increased throughput, faster adoption, and 90% global market share.
THE IMPACT
10-Year
Exclusive design partnership with Illumina's CEO
Defined a unified visual brand language applied across 12+ platforms and products—sustained 80%+ global market share and category leadership
73%
Reduction in user error
Guided workflows and intuitive interaction design enabled confident use in high-stakes lab environments
100+
Countries with Illumina systems
Intuitive UX and modular design accelerated global adoption of Next Gen Sequencing—democratizing research and clinical access globally
MY ROLE
I created and evolved Illumina’s visual brand language and UX—defining the Design DNA of a unified portfolio and leading teams from concept to launch
Partnered directly with the CEO for 10 years, aligning R&D, engineering, and marketing around a unified design vision
Led original design direction and industrial design—improving lab interaction and transforming complex workflows into intuitive, error-reducing user experiences
Created a scalable Experiential Brand Language (XBL)—enabling design and client teams to align quickly and apply it consistently to diverse form factors
Led design and engineering teams over a decade—guiding the evolution of hardware, consumables, workflows, and serviceability across Illumina’s sequencing platforms
GOOD DESIGN Award
For Illumina iScan system
DEEP DIVE:
Designing the DNA of a global brand
Back to Overview
Next: Radiotherapy redefnied

